arrow
K

Kai-Henrik Peiffer

university of munster
H指数:19
被引数:1,454

个人简介

暂无内容

教育背景

暂无内容

工作经历

暂无内容

荣誉奖项

暂无内容

HBV re-activation is associated with increased mortality and dysregulation of oxidative and polyamine metabolism in pre-acute-on-chronic liver failure

HBV再激活与慢加急性肝衰竭前期的死亡率增加以及氧化和聚胺代谢失调相关

2026-08-240
OA
Higher prevalence of Cytomegalovirus and Epstein–Barr virus in acute-on-chronic liver failure

慢性肝病急性发作患者中巨细胞病毒和EB病毒的更高流行率

2025-10-090
OAAI
Generation and Characterization of HDV-Specific Antisera with Respect to Their Application as Specific and Sensitive Research and Diagnostic Tools

HDV特异性抗体的制备与表征及其作为特异性和高灵敏度研究及诊断工具的应用

2025-09-070
OA
Rare HCV subtypes and retreatment outcomes in a cohort of European DAA-experienced patients

欧洲DAA经验患者的罕见HCV亚型和再治疗结果

2024-07-010
OAAI
Terlipressin therapy is associated with increased risk of colonisation with multidrug-resistant bacteria in patients with decompensated cirrhosis
2024-02-275
OAAI
Use and outcome of TIPS in hospitalized patients in Germany: A Nationwide study (2007-2018)
2023-10-015
OAAI
Pathogenetic mechanisms and therapeutic approaches of acute-to-chronic liver failure
2023-07-019
OA
Long-term persistence of HCV resistance-associated substitutions after DAA treatment failure

DAA治疗失败后HCV耐药相关替代的长期持续性

2023-01-0111
PRE
Trends and the course of liver cirrhosis and its complications in Germany: Nationwide population-based study (2005 to 2018)

德国肝硬化及其并发症的趋势和过程: 基于全国人口的研究 (2005 2018年)

2022-01-0174
OA
Cabozantinib in Advanced Hepatocellular Carcinoma: Efficacy and Safety Data from an International Multicenter Real-Life Cohort
2021-06-0121
OAAI